NCT06798363 2026-03-16
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
West China Hospital
Phase 2/3 Recruiting
Clinical Trials
29 trialsNCT05479123 2026-03-13
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
The University of Texas Health Science Center, Houston
Phase 4 Terminated
NCT07436611 2026-02-27
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
AFT Pharmaceuticals, Ltd.
Phase 2 Not yet recruiting
NCT07353385 2026-01-20
Enhanced Efficacy Through Optimization of Hemoporfin-Photodynamic Therapy Parameters in Port-Wine Stains
Second Affiliated Hospital of Xi'an Jiaotong University
Phase NA Completed
NCT07183644 2025-09-19
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
University of Texas Southwestern Medical Center
Phase NA Not yet recruiting
NCT07128459 2025-08-19
macrocheilia
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase NA Completed
NCT05477680 2025-05-16
BRASH
Sklifosovsky Institute of Emergency Care
Phase NA Recruiting
NCT05484219 2025-05-16
FUN
Sklifosovsky Institute of Emergency Care
Phase NA Suspended
NCT06677853 2024-11-07
Timolol Maleate Gel for the Treatment of Infantile Hemangioma
Auson Pharmaceuticals Inc.
Phase 2/3 Completed
NCT02913612 2024-03-12
TIM01
Duke University
Phase 2 Completed
NCT01873131 2023-11-02
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
Massachusetts General Hospital
Phase NA Recruiting
NCT06080724 2023-10-12
hemangioma
King Edward Medical University
Phase NA Completed
NCT00556946 2022-10-21
PDT/PDL
University of California, Irvine
Phase NA Completed
NCT00573729 2022-10-20
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
University of California, Irvine
Phase 1 Completed
NCT02342275 2022-06-16
Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma
West China Hospital
Phase 3 Completed
NCT01010308 2021-08-19
Nadolol for Proliferating Infantile Hemangiomas
The Hospital for Sick Children
Phase 2 Completed
NCT04684667 2020-12-24
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
Assiut University
Phase 2 Unknown
NCT02505971 2020-10-28
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
The Hospital for Sick Children
Phase 3 Completed
NCT04288700 2020-02-28
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma
Ain Shams University
Phase 4 Unknown
NCT03237637 2018-08-28
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3 Unknown
NCT00979550 2018-03-22
The Effects of Aldara as an Adjunct to Laser Treatment
University of Kentucky
Phase 2 Terminated
NCT01147601 2017-07-05
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
Oregon Health and Science University
Phase EARLY_PHASE1 Terminated
NCT01434849 2016-11-15
TiPPIH
The University of Texas Health Science Center at San Antonio
Phase 1 Terminated
NCT01101360 2014-12-02
Port Wine Stains Treatment Matrix RF Study
Syneron Medical
Phase NA Completed
NCT01512173 2014-10-30
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo
Pierre Fabre Dermatology
Phase 2 Completed
NCT01408056 2014-01-17
TOUCH
Children's Hospital of Philadelphia
Phase 2 Withdrawn
NCT00744185 2012-07-19
HEMANGIOMA
University Hospital, Bordeaux
Phase 2/3 Terminated
NCT00365118 2008-06-03
Treatment of Naevus Flammeus Using Intense Pulsed Light and Pulsed Dye Laser
Bispebjerg Hospital
Phase NA Completed
NCT00601016 2008-01-25
A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
St. Justine's Hospital
Phase 2 Completed